What we're reading, April 14, 2016: House passes bill to speed up approval for Zika virus vaccines; spending on prescription brand name drugs grew just 2.8% in 2015; and Maine Senate passes measure to expand Medicaid.
The president’s requested funds to combat the Zika virus may still be tied up in Congress, but the House took its own step to fight the virus. The House approved a bill that would add Zika to a list of diseases qualifying for a priority review voucher, which would speed up FDA approval process for vaccines, reported The Hill. The bill already passed the Senate. The news came at the right time, as CDC researchers also definitively confirmed that Zika causes birth microcephaly and other severe birth defects, reported The Washington Post.
In 2015, the overall spending on prescription drugs rose 8.5%, but spending on brand name drugs rose only 2.8%. According to STAT, the growth in spending on brand name drugs represents a steady decline compared with the 9.1% growth in prices in 2012, which may suggest that pushback against rising prices may be having some success. More than half of the total spending growth in 2015 can be attributed to brand name drugs that have been available for less than 2 years. While spending is still increasing, it is doing so at a slower rate.
A Republican-sponsored measure to expand Medicaid has narrowly passed the Maine Senate. The expansion would provide insurance to nearly 80,000 residents and would bring in more than $2 billion in federal funds over the next 5 years, according to MPBN News. The governor of Maine has vetoed such Medicaid expansion bills in the past.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More